GPX4 and cancer: Knockdown or inhibition of DECR1 siRNA might slow the growth of cancer by increasing polyunsaturated fatty acids (PUFAs) and decreasing monounsaturated fatty acids (MUFAs) in prostate cancer cells, thereby inducing ferroptosis in cells by inhibiting GPX4.